– Genetic testing (including PGT-M) and family screening.
– advanced diagnostic imaging (MRI, echo) and biomarker diagnostics.
– Treatment options including medications, alcohol septal ablation (ASA), SESAME technology, electrophysiological studies, device implantation (pacemakers/ICDs), surgeries like septal myectomy and mitral valve repair.
– Evaluation for heart transplantation in advanced cases.
The establishment of kauvery Hospital’s specialised Hypertrophic Cardiomyopathy Clinic marks a progressive step in addressing critical gaps in the diagnosis and management of this life-threatening condition in India. By offering complete services within one facility-from genetic testing to advanced treatment modalities-the clinic eliminates inefficiencies associated with fragmented care systems while improving patient outcomes through early intervention strategies.
India’s rising burden of noncommunicable diseases highlights the need for such focused multidisciplinary facilities that can provide precise interventions based on cutting-edge technologies like SESAME or PGT-M genetic screening. For HCM patients specifically-who face important risks without timely diagnosis-this integrated approach could serve as a model healthcare delivery mechanism nationwide.
Read more: The Hindu